REGENXBIO, Inc. (RGNX)
5.72
-0.52
(-8.41%)
USD |
NASDAQ |
May 15, 16:00
5.83
+0.11
(+1.92%)
After-Hours: 20:00
REGENXBIO Total Assets (Quarterly) : 341.89M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Sarepta Therapeutics, Inc. | 3.179B |
| Ocugen, Inc. | 56.90M |
| Replimune Group, Inc. | 333.59M |
| AbbVie, Inc. | 136.46B |
| Krystal Biotech, Inc. | 1.397B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 320.81M |
| Shareholders Equity (Quarterly) | 21.08M |
| Debt to Equity Ratio | 11.78 |
| Current Ratio | 2.623 |
| Net Debt Paydown Yield | -4.93% |